ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,875Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 117

$514K Total Retail Price of All Prescriptions

Rank: 41 out of 117

291 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

21% of this provider’s 291 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

0% of this provider’s 9,843 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 502 502 1 1
AMLODIPINE BESYLATE 482 469 2 5
FUROSEMIDE 420 420 3 4
POTASSIUM CHLORIDE 366 366 4 11
HYDROCODONE-ACETAMINOPHEN 299 299 S3 5 3
METOPROLOL TARTRATE 288 288 6 8
LISINOPRIL 281 281 7 6
DONEPEZIL HCL 237 237 8 10
EXELON 237 237 8 34
OMEPRAZOLE 237 232 8 9
SIMVASTATIN 215 215 11 2
ATORVASTATIN CALCIUM 215 215 11 21
METOPROLOL SUCCINATE 179 179 13 17
TRAZODONE HCL 146 146 14 23
TAMSULOSIN HCL 144 144 15 31
DIOVAN 136 136 16 38
CITALOPRAM HBR 125 118 17 18
GABAPENTIN 121 121 18 12
SERTRALINE HCL 117 117 19 16
WARFARIN SODIUM 114 114 20 13
NAMENDA 114 114 20 7
HYDROCHLOROTHIAZIDE 111 111 22 28
PANTOPRAZOLE SODIUM 108 108 23 39
MIRTAZAPINE 99 99 24 14
TRAMADOL HCL 99 99 24 19
METFORMIN HCL 90 90 26 15
ALENDRONATE SODIUM 90 90 26 26
ZOLPIDEM TARTRATE 86 86 28 24
ATENOLOL 86 86 28 42
NEXIUM 82 82 30 36
CLOPIDOGREL 81 81 31 30
POLYETHYLENE GLYCOL 3350 78 78 32 61
LANTUS 75 75 33 25
ENALAPRIL MALEATE 74 74 34 72
GLIPIZIDE 68 68 35 51
DIVALPROEX SODIUM 66 66 36 37
PLAVIX 64 64 37 41
DIGOXIN 63 63 38 45
CRESTOR 62 62 39 58
NITROGLYCERIN PATCH 61 61 40 168
LOSARTAN POTASSIUM 58 58 41 32
AZITHROMYCIN 57 57 42 64
CIPROFLOXACIN HCL 54 54 43 56
RAMIPRIL 53 53 44 63
PREDNISONE 53 53 44 47
FLUTICASONE PROPIONATE 52 49 46 44
ESCITALOPRAM OXALATE 52 52 46 29
ISOSORBIDE MONONITRATE ER 52 52 46 48
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 50 49 90
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.